Germany’s New Government Will Maintain Price Freeze And Slash Free Pricing Period
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.
You may also be interested in...
Industry has warned that reforming the system for evaluating orphan drugs could have serious consequences for patient access.
Pricing reforms in Germany could have a ripple effect elsewhere as other countries look for inspiration on how to reign in pharmaceutical spending.
After years of wrangling, the legislative process for new regulation on greater cooperation on health technology appraisals across the EU has entered its final stages, with parliament expected to adopt the legislation soon.